Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Myoclonus and Myoclonus-Dystonias

Christine Klein*

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Myoclonus is characterized by rapid muscle jerks, while dystonia is defined as sustained twisting and repetitive movements, resulting in abnormal postures. In myoclonus dystonia (M-D), a predominantly myoclonic syndrome is combined with dystonic features. Linkage of autosomal dominantly inherited M-D is demonstrated to a locus on chromosome 7q, designated DYTll, followed by the recent identification of mutations in the 8-sarcoglycan gene (SGCE). However, SGCE clearly represents the major M-D gene. The function of its encoded protein, e-sarcoglycan, is largely unknown. It is a member of the sarcoglycan family, usually involved in muscular dystrophies, while M-D is a non degenerative disorder of the central nervous system. The drugs tested without any good effect on the involuntary movements are-amphetamine, heroin, carbamazepine, propranolol, chlorazepate, and haloperidol. Finally, neuro stimulation of the ventral intermediate thalamic nucleus is shown to be a safe and efficacious treatment in a patient with medically intractable and progressing M-D.

OriginalspracheEnglisch
TitelGenetics of Movement Disorders
Seitenumfang21
Herausgeber (Verlag)Elsevier Inc.
Erscheinungsdatum2003
Seiten451-471
ISBN (Print)9780125666527
DOIs
PublikationsstatusVeröffentlicht - 2003

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Fingerprint

Untersuchen Sie die Forschungsthemen von „Myoclonus and Myoclonus-Dystonias“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren